# Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.

> **NCT05953142** · PHASE2 · UNKNOWN · sponsor: **Federal University of São Paulo** · enrollment: 120 (estimated)

## Conditions studied

- Sepsis
- Hypoperfusion
- Hyperlactatemia

## Interventions

- **DRUG:** Dobutamine

## Key facts

- **NCT ID:** NCT05953142
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05953142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05953142, "Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05953142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*